हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Lincoln Pharma is exploring new areas in African, EU & South-East Asian countries: Mahendra Patel, MD
Wed, Nov 25, 2020
Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd, talks about the sales and export markets, new geographies of expansion, launches of new products and CapEx among others during a candid chat with Zee Business Executive Editor Swati Khandelwal
Govt move to incentivise API exports a big boost for sector, IOL Chemicals Jt MD Vijay Garg tells Anil Singhvi
Tue, Oct 27, 2020
Zee Business’ exclusive news on government's plans to incentivise exports in the API manufacturing was spot on regarding incentives for the domestic API manufacturing segment. In a chat with Managing Editor Anil Singhvi, IOL Chemicals and Pharmaceuticals Limited’s Joint Managing Director Vijay Garg explains what it means for the sector and his company and impact on China
Stocks To Buy Today With Anil Singhvi: Know why Sandeep Jain is bullish on pharma and GTB
Tue, Sep 01, 2020
Stocks To Buy Today With Anil Singhvi: In yet another edition of 'GEMS by Jain Sahib' show, market analyst Sandeep Jain brings a stock that has great potential to earn high returns for investors. This stock is from the pharmaceutical sector, a sector that this technical analyst is extremely bullish on
Stocks to Buy: GEMS that put health In your wealth - Sandeep Jain reveals to Anil Singhvi why investors should buy these 2 stocks
Tue, Jul 28, 2020
In yet another extremely captivating show on Zee Business, Managing Editor Anil Singhvi has charted an agenda where individual analysts in his panel of experts have been tagged with extremely entertaining nicknames that matches their powerful investing style. Here we look at 'GEMS by Jain Sahib'. Market analyst Sandeep Jain has recommends two stocks
Non-price control medicines price to get reduced
Wed, Nov 27, 2019
Non-price control medicines price to get reduced. Watch this video to know more.
Indian healthcare may grow threefold to $372 billion by 2022: Assocham
Sun, Dec 03, 2017
The Indian healthcare market is likely to reach $372 billion by 2022 in a threefold growth in value terms, industry chamber Assocham said on Sunday, citing its latest study on the subject.
Panacea Biotec signs seven drugs deal with Bionpharma Inc
Fri, Jul 28, 2017
Key Highlights 7 drugs represent a total estimated market potential of more than $800 million
Dr Reddy's Laboratories Q4 review: Here's what to expect
Fri, May 12, 2017
In Q3FY17, the company reported consolidated net profit of Rs 492.3 crore, down 15.94% year-on-year compared to Rs 585.7 crore in the corresponding period of the previous year.
We have a wide trade deficit with China, says Shaktikanta Das
Mon, Feb 13, 2017
Shaktikanta Das said that they are working to increase their exports in China and to decrease the trade deficit.
GlaxoSmithKline Pharma's Q3 net profit down 33%
Sat, Feb 11, 2017
The company reported net profit of Rs 52.95 crore, a drop of 32.91% from Rs 78.93 crore in the corresponding period of the previous year.
Lupin's Q3 net profit rise by 21%; shares trade high
Thu, Feb 09, 2017
Pharmaceutical-major Lupin on Thursday reported 21% rise in net profit during the quarter ended on December 31.
Q3FY17: Dr Reddy's Laboratories' net profit down 19% at Rs 470 crore
Sat, Feb 04, 2017
GV Prasad, Co-chairman of Dr Reddy's Laboratories said, "Our performance in Q3 has delivered a modest sequential revenue growth of 3% over the previous quarter. Our EBITDA has improved significantly from the last quarter to Rs 8.8 billion, on the back of enhanced emphasis on operational efficiencies and controlling of SG&A cost across all our business."
Divi's Laboratories report 9% rise in net profit in Q3
Sat, Feb 04, 2017
Updating on US-FDA inspection, Divi's Lab said, "It has filed its comprehensive response to the observations of the FDA regulator within the stipulated time. Now it awaits for review from the US pharma regulator.
Glenmark Pharma's Q3 net profit rise by 143% to Rs 477 crore
Thu, Feb 02, 2017
The company's total income increased to Rs 2549.5 crore in Q3FY17 as compared to Rs 1780.4 crore in Q3FY16.
Natco Pharma drops as USFDA makes six observations
Wed, Jan 25, 2017
Shares of Natco Pharma dropped 0.22% on NSE Nifty after the company said that USFDA conducted an inspection at its pharmaceutical factory in Kothur, near Hyderabad between January 16-24, 2017.
Pharma Q3: FDA inspection, US pricing market key
Thu, Jan 12, 2017
Piyush Nahar and Anurag Mantry analysts of Jefferies said, “We expect another muted quarter for the pharma sector led by weakness in US business. USFDA inspections and pricing in US market will continue to dominate the results. Recent comments from global peers have indicated that pricing scenario will likely remain unchanged in 2017.”
Zydus Cadila acquires six brands from American pharma MSD
Wed, Dec 28, 2016
Though the companies have not disclosed the financial details of the deal.
Divi's laboratories drops over 10% on USFDA reports
Mon, Dec 26, 2016
Pharmaceutical major Divi's Laboratories Ltd continued to fall on Monday with the stock cracking over 10%, or Rs 85.75 per share.
Sun Pharma arm picks up 14.6% stake in US company for $13 million
Fri, Dec 23, 2016
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%
Thu, Dec 22, 2016
"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.